EGFR and gastric cancer: Actually, our findings showed that inhibition of EGFR activity by pyrotinib blocks GRP78 phosphorylation, subsequently improves GRP78 ubiquitination and proteasomal degradation, and finally enhance apoptosis induced by oxaliplatin stress in EGFR-high CN GC cells.